GSK-3β inhibition in pancreatic cancer cells leads to perturbations in Rac1 and F-actin subcellular localization, reduced production of MMP-2, and decreased phosphorylation of FAK, leading to inhibition of cell migration and invasion. Here, MMP2 is linked to familial pancreatic carcinoma.